Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

MLA

Mark Westwood, et al. Randomized Controlled Trial of Deferiprone or Deferoxamine in Beta-Thalassemia Major Patients with Asymptomatic Myocardial Siderosis. Jan. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5732e22eef28209806b1019b675783d&authtype=sso&custid=ns315887.

APA

Mark Westwood, Antonio Piga, Athanassios Aessopos, Renzo Galanello, Mark A. Tanner, Beatrix Wonke, Efstathios D Gotsis, Vasili Ladis, Gill C. Smith, Vasili Berdoukas, Dudley J. Pennell, & Markissia Karagiorga. (2006). Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Chicago

Mark Westwood, Antonio Piga, Athanassios Aessopos, Renzo Galanello, Mark A. Tanner, Beatrix Wonke, Efstathios D Gotsis, et al. 2006. “Randomized Controlled Trial of Deferiprone or Deferoxamine in Beta-Thalassemia Major Patients with Asymptomatic Myocardial Siderosis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5732e22eef28209806b1019b675783d&authtype=sso&custid=ns315887.